ACS Medicinal Chemistry Letters
Letter
(11) Fabisiak, J. P.; Tyurina, Y. Y.; Tyurin, V. A.; Kagan, V. E.
Quantification of selective phosphatidylserine oxidation during
apoptosis. Methods Mol. Biol. 2005, 291, 2005.
(12) Imai, H.; Nakagawa, Y. Biological significance of phospholipid
hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian
cells. Free Radical Biol. Med. 2003, 34, 2003.
(13) Nomura, K.; Imai, H.; Koumura, T.; Kobayashi, T.; Nakagawa,
Y. Mitochondrial phospholipid hydroperoxide glutathione peroxidase
inhibits the release of cytochrome c from mitochondria by suppressing
the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis.
Biochem. J. 2000, 351, 2000.
(14) Nomura, K.; Imai, H.; Koumura, T.; Nakagawa, Y. Involvement
of mitochondrial phospholipid hydroperoxide glutathione peroxidase
as an antiapoptotic factor. Biol. Signals Recept. 2001, 10, 2001.
(15) Epperly, M. W.; Melendez, J. A.; Zhang, X.; Nie, S.; Pearce, L.;
Peterson, J.; Franicola, D.; Dixon, T.; Greenberger, B. A.; Komanduri,
P.; Wang, H.; Greenberger, J. S. Mitochondrial targeting of a catalase
transgene product by plasmid liposomes increases radioresistance in
vitro and in vivo. Radiat. Res. 2009, 171, 2009.
postirradiation treatment. This is an important pharmacological
advantage, as IR damage to organisms is often the result of
accidents, whereby immediate post-IR treatment may be
impractical.
ASSOCIATED CONTENT
■
S
* Supporting Information
Details of biological assays, chemical synthesis, and structural
analysis. This material is available free of charge via the Internet
AUTHOR INFORMATION
■
Corresponding Authors
(16) Tak, J. K.; Park, J. W. The use of ebselen for radioprotection in
cultured cells and mice. Free Radical Biol. Med. 2009, 46, 2009.
(17) Aitken, J. B.; Lay, P. A.; Duong, T. T.; Aran, R.; Witting, P. K.;
Harris, H. H.; Lai, B.; Vogt, S.; Giles, G. I. Synchrotron radiation
induced X-ray emission studies of the antioxidant mechanism of the
organoselenium drug ebselen. J. Biol. Chem. 2012, 17, 2012.
(18) Azad, G. K.; Tomar, R. S. Ebselen, a promising antioxidant drug:
mechanisms of action and targets of biological pathways. Mol. Biol.
Rep. 2014, 41, 2014.
(19) Singh, N.; Halliday, A. C.; Thomas, J. M.; Kuznetsova, O. V.;
Baldwin, R.; Woon, E. C.; Aley, P. K.; Antoniadou, I.; Sharp, T.;
Vasudevan, S. R.; Churchill, G. C. A safe lithium mimetic for bipolar
disorder. Nat. Commun. 2013, 4, 2013.
(20) Filipovska, A.; Kelso, G. F.; Brown, S. E.; Beer, S. M.; Smith, R.
A.; Murphy, M. P. Synthesis and characterization of a triphenylphos-
phonium-conjugated peroxidase mimetic. Insights into the interaction
of ebselen with mitochondria. J. Biol. Chem. 2005, 280, 2005.
(21) Smith, R. A.; Hartley, R. C.; Murphy, M. P. Mitochondria-
targeted small molecule therapeutics and probes. Antioxid. Redox
Signaling 2011, 15, 2011.
(22) Kabe, Y.; Ohmori, M.; Shinouchi, K.; Tsuboi, Y.; Hirao, S.;
Azuma, M.; Watanabe, H.; Okura, I.; Handa, H. Porphyrin
accumulation in mitochondria is mediated by 2-oxoglutarate carrier.
J. Biol. Chem. 2006, 281, 2006.
(23) Stoyanovsky, D. A.; Huang, Z.; Jiang, J.; Belikova, N. A.; Tyurin,
V.; Epperly, M. W.; Greenberger, J. S.; Bayir, H.; Kagan, V. E. A
manganese-porphyrin complex decomposes H(2)O(2), inhibits
apoptosis, and acts as a radiation mitigator in vivo. ACS Med. Chem.
Lett. 2011, 2, 2011.
(24) Puntel, R. L.; Roos, D. H.; Folmer, V.; Nogueira, C. W.; Galina,
A.; Aschner, M.; Rocha, J. B. Mitochondrial dysfunction induced by
different organochalchogens is mediated by thiol oxidation and is not
dependent of the classical mitochondrial permeability transition pore
opening. Toxicol. Sci. 2010, 117, 2010.
(25) Press, D. J.; Mercier, E. A.; Kuzma, D.; Back, T. G. Substituent
effects upon the catalytic activity of aromatic cyclic seleninate esters
and spirodioxyselenuranes that act as glutathione peroxidase mimetics.
J. Org. Chem. 2008, 73, 2008.
(26) Bhabak, K. P.; Mugesh, G. Functional mimics of glutathione
peroxidase: bioinspired synthetic antioxidants. Acc. Chem. Res. 2010,
43, 2010.
Funding
This work was supported by NIH Grant U19AI068021,
HL114453 and NS061817, and Human Frontier Science
Program RGP0013.
Notes
The authors declare no competing financial interest.
ABBREVIATIONS
■
GPx, glutathione peroxidase; ER, endoplasmic reticulum; IR,
ionizing radiation; RMs, radiation mitigators; RPs, radiation
protectors; WBI, whole-body irradiation; MEC, mouse
embryonic cells
REFERENCES
■
(1) Weiss, J. Radiochemistry of aqueous solutions. Nature 1944, 153,
1944.
(2) Patt, H. M.; Tyree, E. B.; Straube, R. L.; Smith, D. E. Cysteine
protection against X irradiation. Science 1949, 110, 1949.
(3) Bacq, Z. M.; Herve, A.; Fischer, P.; Lecomte, J.; Pirotte, M.;
Deschamps, G.; Le Bihan, H.; Rayet, P. Preventive and therapeutic
effects of mercapto-ethylamin (becaptan) on radiation sickness. Rev.
Med. Liege 1953, 8, 1953.
(4) Radivojevitch, D.; Bacq, Z. M.; Beaumariage, M. L. Radio-
protective action of cysteamine, cystamine and histamine on the
dipilation of the young mouse exposed to x-radiation. J. Physiol. 1960,
52, 1960.
(5) Sweeney, T. R. A Survey of Compounds from the Antiradiation
Drug Development Program of the US Army Medical Research and
Development Command; Walter Reed Army Institute of Research:
Washington, DC, 1979.
(6) Kouvaris, J. R.; Kouloulias, V. E.; Vlahos, L. J. Amifostine: the first
selective-target and broad-spectrum radioprotector. Oncologist 2007,
12, 2007.
(7) Kam, W. W.; Banati, R. B. Effects of ionizing radiation on
mitochondria. Free Radical Biol. Med. 2013, 65, 2013.
(8) Coelho, D.; Holl, V.; Weltin, D.; Lacornerie, T.; Magnenet, P.;
Dufour, P.; Bischoff, P. Caspase-3-like activity determines the type of
cell death following ionizing radiation in MOLT-4 human leukaemia
cells. Br. J. Cancer 2000, 83, 2000.
(9) Bayir, H.; Kagan, V. E.; Borisenko, G. G.; Tyurina, Y. Y.; Janesko,
K. L.; Vagni, V. A.; Billiar, T. R.; Williams, D. L.; Kochanek, P. M.
Enhanced oxidative stress in iNOS-deficient mice after traumatic brain
injury: support for a neuroprotective role of iNOS. J. Cereb. Blood Flow
Metab. 2005, 25, 2005.
(10) Kagan, V. E.; Bayir, H.; Shvedova, A. A. Nanomedicine and
nanotoxicology: two sides of the same coin. Nanomedicine 2005, 1,
2005.
D
dx.doi.org/10.1021/ml5003635 | ACS Med. Chem. Lett. XXXX, XXX, XXX−XXX